Differences in UK healthcare professionals' knowledge, attitude and practice towards infliximab and insulin glargine biosimilars.

Mohammed Ibrahim AladulRaymond W FitzpatrickStephen Robert Chapman

Published in: The International journal of pharmacy practice (2018)

Healthcare professionals were more comfortable with the initiation of biosimilars than switching current patients. Medical consultants/registrars and pharmacists were more informed than nurses.

Keyphrases

healthcare
end stage renal disease
type diabetes
chronic kidney disease
primary care
mental health
prognostic factors
peritoneal dialysis
glycemic control
quality improvement
adipose tissue
patient reported outcomes
skeletal muscle